[1] Fricker LD.Neuropeptidomics to study peptide processing in animal models of obesity[J].Endocrinology,2007,148:4185-4190. [2] Loh K,Herzog H,Shi YC.Regulation of energy homeostasis by the NPY system[J].Trends Endocrinol Metab,2015,26:125-135. [3] Shi YC,Lau J,Lin Z,et al.Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN[J].Cell Metab,2013,17:236-248. [4] Kuo LE,Kitlinska JB,Tilan JU,et al..Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome[J].Nat Med,2007,13:803-811. [5] Vogel H,Wolf S,Rabasa C,et al.GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight[J].Neuropharmacology,2016,110:396-406. [6] El BR,Coin-Araguez L,Fernandez-Garcia D,et al.Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes[J].Br J Pharmacol,2016,173:1820-1834. [7] Xu F,Lin B,Zheng X,et al.GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1[J].Diabetologia,2016,59:1059-1069. [8] Garin MC,Burns CM,Kaul S,et al.Clinical review:The human experience with ghrelin administration[J].J Clin Endocrinol Metab,2013,98:1826-1837. [9] Mihalache L,Gherasim A,Nita O,et al.Effects of ghrelin in energy balance and body weight homeostasis[J].Hormones (Athens),2016,15:186-196. |